Recent Transactions

17-Nov-20
$497 million
United States flag
Target: 

Gannett Co., Inc.

flag not available
Acquiror: 
N/A

Advised Gannett Co., Inc., a news media and marketing solutions company, on the refinancing of ~$500mm of its term loan with convertible notes

07-Nov-11
$398 million
United States flag
Target: 

American Dental Partners, Inc.

United States flag
Acquiror: 
JLL Partners

Advised American Dental Partners, Inc. (NASD: ADPI), one of the nation’s leading business partners to dental group practices, on its sale to JLL Partners, a leading private equity firm

25-Jan-17
$325 million
United States flag
Target: 

Ad Hoc Group of Senior Secured Noteholders

flag not available

Advised the Ad Hoc Group of Senior Secured Noteholders in connection with the restructuring of Goodman Networks.

18-Jan-22
$321 million
United States flag
Target: 

Fusion Connect, Inc.

flag not available
Acquiror: 
N/A

Advised Fusion Connect, Inc., a leading service provider of cloud communications and secure network solutions with a focus on serving mid-market and enterprise businesses on its comprehensive balance sheet recapitalization

28-Jun-12
$275 million
United States flag
Target: 

Village Roadshow Entertainment Group

Advised Village Roadshow Entertainment Group on its $275 million mezzanine and equity capital raise from a group of investors

04-Oct-16
$223 million
U.S.A., U.K. flags
Target: 

US rights to Toprol-XL (AstraZeneca)

Canada flag
Acquiror: 
Aralez Pharmaceuticals Inc.

Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the US rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.

30-Dec-22
$153 million
United States flag
Target: 

Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products

Australia flag
Acquiror: 
Mayne Pharma

Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma

25-May-17
$115 million
United States flag
Target: 

F+W Media

flag not available

Advised F+W Media, a content and e-commerce company focused on a variety of special interest categories, on the out-of-court restructuring of its c.$100 million term loan and a $15 million new money investment from existing lenders

19-Feb-21
$33 million
U.S.A., U.K. flags
Target: 

Acacia Pharma Group plc

flag not available
Acquiror: 
N/A

Advised Acacia Pharma Group plc, a US headquartered commercial stage biopharmaceutical company incorporated in England and listed in Belgium, on its placing of 10m new ordinary shares at a price of €2.70 per share

13-Aug-12
$32 million
United States flag
Target: 

Journal Communications, Inc.

Advised the Board of Directors of Journal Communications, Inc., a diversified media company with newspaper and broadcasting interests, in connection with the repurchase of 100% of the issued and outstanding shares of its Class C Common Stock from successors to the Company’s founding family

02-Dec-10
$NA
United States flag
Target: 

IAC / InterActiveCorp.

Advised the Special Committee of the Board of Directors of IAC, a leading Internet company, on the repurchase of all IAC shares owned by Liberty Media in exchange for a combination of cash and two operating businesses, Evite and Gifts.com

09-Feb-21
Undisclosed
United States flag
Target: 

US Acute Care Solutions

United States flag
Acquiror: 
Apollo Hybrid Value Fund

Advising US Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on its recapitalization and buyout of minority partner, Welsh Carson

01-Apr-13
$NA
United States flag
Target: 

Morgans Hotel Group

Advised the Special Transaction Committee of the Board of Morgans Hotel Group on the transfer of its ownership interests in Delano South Beach and The Light Group to The Yucaipa Companies in exchange for the cancellation of certain securities held by Yucaipa (debt, preferred stock and warrants) together with a $100 million rights offering backstopped by Yucaipa

05-Aug-14
$NA
United States flag
Target: 

Gannett Co., Inc.

flag not available

Advised Gannett Co., Inc. a media and marketing solutions company, on the spin-off of its Publishing business and the creation of two separate media companies: one focused on television broadcasting and digital marketing and one focused on newspapers.

13-Oct-16
$NA
U.S.A., Canada flags
Target: 

Concordia International Corp

flag not available

Advised the Special Committee of the Board of Directors of Concordia International, a diverse, international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, on its strategic review process

02-Nov-16
$NA
United States flag
Target: 

IAC/InterActiveCorp

flag not available

Advised the Special Committee of the Board of Directors of IAC/InterActiveCorp, a leading media and internet company, on the potential creation of a new class of non-voting common stock 

27-Sep-23
Undisclosed
United States flag
Target: 

Slayback Pharma LLC

United States flag
Acquiror: 
Azurity Pharmaceuticals

Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products

10-Jun-19
$NA
United States flag
Target: 

Book Publishing Business of F+W Media

United States flag
Acquiror: 
Penguin Random House

Advised F+W Media, a content and e-commerce company focused on a variety of special interest categories, on the sale of its book publishing business as part of its broader in-court restructuring

10-Aug-06
$NA
United States flag
Target: 

Forest City Ratner

United States flag
Acquiror: 
Forest City Enterprises Inc.

Advised Forest City Enterprises, Inc. on the restructuring of its business relationship with its New York City affiliate Forest City Ratner

Pages

show all